Composed of bioactive collagen peptides, L-arginine, zinc, selenium and vitamins A, C and E, its formulation contributes to proper nutrition focused on the recovery of patients with acute or chronic wounds
The STEP program encompasses five phase 3 trials that focus on the different aspects of weight management, including weight management in type 2 diabetes, weight management with intensive behavioral therapy, sustained weight management, and long-term weight management
Risk factors that might warrant consideration of medication adjustment include: Recent initiation or dose escalation of GLP-1 therapy Significant gastrointestinal symptoms (nausea, vomiting, early satiety) Maximum medication doses Known gastroparesis or other conditions affecting gastric emptying For patients where holding the medication is deemed appropriate, the duration should be individualized based on the specific medication, patient factors, and clinical judgment
Pathog Dis (2017) 75(7):ftx093